Archives

OptimHal-ProtecSom present at the next Normand Pediatric Seminar

On Thursday, March 22, 2018 will be held the 30th Normand Pediatric Seminar, which takes place as every year, in Hérouville-Saint-Clair, near Caen (14).

 

This new edition, organized by Professor Jacques BROUARD, Head of Pediatric Department at the University Hospital of Caen, will gather many specialists in asthma and allergy in the Normandy region, working in the field of pediatrics. The theme of the seminar will be: “What prospects for limiting antibiotic prescriptions in pediatrics in 2018? “

 

This day will be punctuated by communications about pediatric surgery, child psychiatry and neonatology from the University Hospital of Caen.

 

As for many years and as Normand Laboratory, we will be present during this day to meet and exchange with the leading local specialists in asthma and allergies and to enhance our medical devices “made in Normandy” .

 

Find the full program of the 30th Normand Pediatric Seminar here.

 

Adress : Hôtel Mercure, 2 Place de Boston, 14200 Hérouville-Saint-Clair

Arab Health – DubaÏ : Come meet us !

 

From January 29 to February 1, 2018 will be held the Arab Health, which takes place as every year at the International Center of Congresses and Exhibitions of Dubai. (United Arab Emirates)

 

This fair, large and internationally renowned, is the unmissable event in the field of the pharmaceutical industry and medical devices. Arab Health attracted nearly 4,000 exhibitors from 40 different countries in 2017.

 

Find us at the French pavilion in Hall Z2 on B35 booth to discover our interfaces of inhalation dedicated to respiratory diseases as the TipsHaler® valved holding chamber or the OrHal® partitioned mask… but also our protective devices for the allergic patients as the Texaal® dust mite covers.

 

For more information : Arab Health


ProtecSom-OptimHal present at the next CPLF (Lyon, France)

ProtecSom-OptimHal CPLF 2018

 

 

From January 26 to 28, 2018 will be held the 22nd edition of the Congress of Pneumology of French Language (CPLF), which will take place this year at the Palais des Congrès in Lyon (France).

 

This new edition will bring together nearly 5,000 health professionals, working in particular in the field of pneumology and will be on the theme : “Thoracic oncology – The lung and its environment“.

 

This congress is the opportunity to meet and exchange with many specialists in asthma : respirologists, allergists, patient associations… 

 

 

 

At this occasion, we will be delighted to welcome you on our booth (80), to present the inhalation devices from ProtecSom-OptimHal research : 


  • TipsHaler®, first valved holding chamber optimized for control treatments and especially inhaled corticosteroids.
  • CombiHaler®, the spacer for mechanical ventilation circuits.

Looking forward to meeting you in Lyon and to exchange with you !

 

More information about the program of this 22nd edition.

Guest Book – Extract

Guest Book - ProtecSom

 

 

 

 

 

« Purchase of “renewal” for my 12-year-old girl who is asthmatic since she was 4 years old. For some time, she has been sleeping with two pillows, one of which was not wrapped, and I have noticed a worsening of sneezing. So I try to wrap this 2nd pillow to limit its reaction to mites. Stay tuned…
PS: The rest of the bedding is protected for a long time and I am very satisfied with ProtecSom products. »

 

Extract from a satisfaction questionnaire

 

Guest Book – Laboratoire ProtecSom 


2017 : An encouraging year for CombiHaler® !

The year 2017 has been fruitful for CombiHaler®, our spacer for mechanical ventilation circuits. Several scientific publications published this year reveal the eagerness of the scientific community to work with our spacer for mechanical ventilation circuits, developed jointly with “l’Université de Tours”.



By studying the feasibility to connect CombiHaler® on different types of circuits (high flow nasal canula and single-limb non-invasive ventilation), the first 2 articles (Madney, 2017 and Harb, 2017) have opened up new prospects for the use of CombiHaler®.

The last article published in October (Rodriguez, 2017) presents encouraging results for the treatment of pulmonary infections that requires high antibiotics concentrations. By increasing the dose delivered directly de the patients’ lungs, the dose of antibiotics to the site of infection is increased, systemic side effects are reduced, and antibiotic resistance accrual is potentially limited.

This enthusiasm from the scientific community hints at a very bright future for CombiHaler® and its evolutions of our range of spacers for mechanical ventilation.

Prix Galien – Medstartup : Historic double victory for ProtecSom-OptimHal !

Official : Following its nomination, Laboratoire ProtecSom-OptimHal announces its double victory, in partnership with Virginia Commonwealth University, l’Association Pulmonaire in Québec and PharmaSystems in two categories of the 2017 Prix Galien – MedstartUp, organized by the Galien Foudation and Business France.



An internationally recognized prestigious award

Dedicated to innovation since 1970, the Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation that improves the state of human health.

The most innovative Franco-American collaborations have been awarded during the Prix Galien – MedstartUp ceremony on Thursday 26 October in New-York.



A rigorous selection dedicated to global excellence

Following a drastic selection, only  11 out of 50 companies were nominated for the innovative aspect of their healthcare solutions.


ProtecSom-OptimHal laboratory was rewarded for :


« The Best Collaboration with academia Leading to a Breakthrough Solution »


A partnership with the Virginia Commonwealth University, Professor Bruce Rubin and PharmaSystems Inc.


« The Best Use of Patient Engagement Technologies »


A partnership with L’Association Pulmonaire in Québec and PharmaSystems Inc.


This historic victory is a great achievement for ProtecSom-OptimHal, thus proving recognition for its efforts in terms of innovation for healthcare.


A word from the Scientific Director 

« I am very proud of these two successes and I congratulate our research teams for the quality of their work that has enabled these partnerships. This is an important asset for our company on American soil where we find ourselves partners with Professor Bruce Rubin whose life is dedicated to the health of children. » – Thierry Porée


We would like to thank all our partners that contributed to the success of our project and without whom nothing could have been possible : Professor Bruce Rubin – Business France –CCI Normandie – Association Pulmonaire in Québec – PharmaSystems


The Galien – MedStartUp Awards: ProtecSom OptimHal nominee in two categories

The Galien foundation, a true catalyst for the development of health technologies, pairs every year with Business France to encourage, recognize and reward transatlantic partnerships projects.



ProtecSom-OptimHal a finalist in two categories

Since 2014, the MedStartUp Awards honour innovation, scientific excellence, and commercial potential of French-American projects. Preselected in 2016, the Laboratoire ProtecSom-OptimHal’s project is the only one to be selected as one of the 3 finalists in two categories:

 

  • Best Use of Health Patient Engagement Technologies
  • Best Collaboration or Partnership with Academia Leading to a Breakthrough Solution

DigitHal® enhances patients’ technique and observance

The nominated project, DigitHal®, by providing real time data on patient’s drug inhalation, intends to enhance technique and observance, parameters that are essentials, yet often lacking. OptimHal®’s new device will therefore provide a more comprehensive solution to the administration and monitoring of inhaled treatments.

 

ProtecSom-OptimHal, the wish to generate reel progress for patients and caretakers

This nomination is, in itself, a recognition of the innovative nature of the Laboratoire ProtecSom-OptimHal, that has since 2003 consistently proposed new devices, always with the wish to generate reel progress for patients and caretakers. It also validates the relevance of our broad partnership policy, demonstrated here with two collaborators:

 

  • Pr Bruce Rubin and the Virginia Commonwealth University, renowned throughout the world for their knowledge of inhaled treatment and pediatric medicine.
  • L’association pulmonaire du Québec, founded in 1938, a non-profit involved with the promotion of respiratory health and prevention of pulmonary diseases through research and education.

The winners will be selected by a world renown scientific committee and announced on October 2017, 26th in New York during the MedStartUp Days.